Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000239376

Medchemexpress LLC 3-methoxy-n-(1-methylpiperidin-4-yl)-4-[[4-[(3-oxo-1,2-dihydroinden-4-yl)oxy]-5-(trifluoromethyl)pyr | 1227948-02-8 | 98.6% | 555.55 | C28H28F3N5O4 | 100MG
SDP

Catalog No. 5000239376
Encompass_Preferred

BI-4464 is a selective, ATP-competitive inhibitor of focal adhesion kinase (PTK2/FAK) used as a research tool in biochemical and cellular studies and as a PTK2 ligand for PROTAC development. It shows potent enzymatic inhibition and is supplied with analytical documentation for preclinical research.

  • Highly selective ATP-competitive PTK2/FAK inhibitor.
  • Potent enzymatic activity (IC50 17 nM).
  • Suitable as a PTK2 ligand for PROTAC design.
  • Supplied with certificate of analysis and safety data sheet for quality assurance.
  • Available in multiple pack sizes for research use.

Catalog No. 50-002-39376 Supplier Medchemexpress LLC Supplier No. HY124625100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BI-4464 is a selective, ATP-competitive inhibitor of focal adhesion kinase (PTK2/FAK) used as a research tool in biochemical and cellular studies and as a PTK2 ligand for PROTAC development. It shows potent enzymatic inhibition and is supplied with analytical documentation for preclinical research.

  • Highly selective ATP-competitive PTK2/FAK inhibitor.
  • Potent enzymatic activity (IC50 17 nM).
  • Suitable as a PTK2 ligand for PROTAC design.
  • Supplied with certificate of analysis and safety data sheet for quality assurance.
  • Available in multiple pack sizes for research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.